Hyundai ADM Bio Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 2,530.00
+150.00 (6.30%)
At close: Oct 2, 2025
Hyundai ADM Bio Revenue
In the year 2024, Hyundai ADM Bio had annual revenue of 9.74B KRW, down -29.33%.
Revenue
9.74B
Revenue Growth
-29.33%
P/S Ratio
14.44
Revenue / Employee
60.91M
Employees
160
Market Cap
140.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.74B | -4.05B | -29.33% |
| Dec 31, 2023 | 13.79B | -1.09B | -7.34% |
| Dec 31, 2022 | 14.88B | 904.78M | 6.47% |
| Dec 31, 2021 | 13.98B | 857.61M | 6.54% |
| Dec 31, 2020 | 13.12B | 2.91B | 28.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Doosan Enerbility | 16.30T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |